Morphine is an highly addictive substance, both psychologically and physically, with an addiction potential indistinguishable from heroin, which is a morphine pro-drug. In a study comparing the physiological and subjective effects of heroin and morphine administered intravenously in post-addicts, the post-addicts showed no preference for one or the other of these drugs when administered on a single injection basis. Equipotent doses of these drugs had quite comparable action time courses when administered intravenously, and on this basis there was no difference in their ability to produce feelings of "euphoria," ambition, nervousness, relaxation, drowsiness, or sleepiness. Although the heroin abstinence syndrome was of shorter duration than that of morphine, the peak intensity was quite comparable for the two drugs. Data acquired during short-term addiction studies did not support the statement that tolerance develops more rapidly to heroin than to morphine. These findings have been discussed in relation to the physiochemical properties of heroin and morphine and the metabolism of heroin. When compared to other opioids — hydromorphone, fentanyl, oxycodone, and meperidine — post-addicts showed a strong preference for heroin and morphine over the others, suggesting that heroin and morphine are more liable to abuse and addiction. The findings in this relatively new study lends more credence to more than four dozen research experiments previously conducted in the United States, Canada, Sweden, Germany, and Japan on the abuse potential of various narcotics. All research papers have concluded that morphine and heroin were much more likely to produce feelings of euphoria and other such subjective effects when compared to most other opioid analgesics. Virtually every narcotic analgesic on the market has been put up against heroin and morphine, including oxymorphone, hydrocodone, codeine, levorphanol, methadone, nicomorphine, and as already mentioned, fentanyl, pethidine, hydromorphone, and oxycodone.
Sources:
Journal of Pharmacology And Experimental Therapeutics, Vol. 133, Issue 3, 388-399, 1961
1 National Institute of Mental Health, Addiction Research Center, U. S. Public Health Service Hospital, Lexington, Kentucky
W. R. Martin 1 and H. F. Fraser 1
University of Arizona, Tucson - Pharmacology Department
Wang C-Q, Li Y, Douglas SD, Wang X, Metzger DS, Zhang T, Ho W-Z: Morphine withdrawal enhances hepatitis C virus (HCV) replicon expression. Am J Pathol 2005, 167:1333-1340
David Shewan, Phil Dalgarno (2005). "Evidence for controlled heroin use? high levels of negative health and social outcomes among non-treatment heroin users in Glasgow". British Journal of Health Psychology 10: 33-48. doi:10.1348/135910704X14582
Thomas, Josephine (May 2001). Buprenorphine Proves Effective, Expands Options For Treatment of Heroin & Morphine Addiction (PDF). NIDA Notes: Articles that address research on Heroin 23; Morphine resurgance; Smokeable Crystalized Morphine. National Institute on Drug Abuse. Retrieved on May 5, 2006